SCHEMBL14515519

SCHEMBL14515519

O=C(O)c1cccnc1CI

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.57
TDP1 Q9NUW8 1/20 0.57
ALDH1A1 P00352 7/20 0.55
ALOX15 P16050 2/20 0.55
L3MBTL1 Q9Y468 2/20 0.55
CYP3A4 P08684 1/20 0.55
MAPT P10636 1/20 0.55
TSHR P16473 1/20 0.55
BLM P54132 1/20 0.55
AGER Q15109 1/20 0.55
NPSR1 Q6W5P4 1/20 0.55
SMN1; SMN2 Q16637 3/20 0.53
NAPRT Q6XQN6 2/20 0.53
LMNA P02545 2/20 0.53
CYP2C9 P11712 1/20 0.46
DHODH Q02127 2/20 0.46
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
GAA P10253 1/20 0.45
MYC P01106 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3664193 0.83 PARP1 (0.51) KDM4ETDP1ALDH1A1ALOX15L3MBTL1
SCHEMBL3880000 0.82 KDM4E (0.59) KDM4ETDP1ALDH1A1ALOX15L3MBTL1
SCHEMBL5252687 0.82 KDM4E (0.59) KDM4ETDP1ALDH1A1ALOX15L3MBTL1
SCHEMBL25718894 0.81 KDM4E (0.53) KDM4ETDP1ALDH1A1ALOX15L3MBTL1
SCHEMBL3931891 0.81 NAPRT (0.58) KDM4ETDP1ALDH1A1ALOX15L3MBTL1
SCHEMBL123202 0.81 KDM4E (0.57) KDM4ETDP1ALDH1A1ALOX15L3MBTL1
SCHEMBL2782918 0.81 KDM4E (0.62) KDM4ETDP1ALDH1A1ALOX15L3MBTL1
SCHEMBL242926 0.81 SMN1; SMN2 (0.58) KDM4ETDP1ALDH1A1ALOX15L3MBTL1
SCHEMBL188175 0.81 NAPRT (0.58) KDM4ETDP1ALDH1A1ALOX15L3MBTL1
SCHEMBL2300950 0.81 NAPRT (0.58) KDM4ETDP1ALDH1A1ALOX15L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1798230-A1 Substituted alkylamine derivatives and methods of use Amgen Inc. (US) 2007-06-20 EP disclosed